Healthcare provider profile · identity verified

Kathy Ann Christopher, M.D.

Family Practice · MODESTO, CA · NPI 1487668273

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	434	140
Levothyroxine Sodium	Levothyroxine Sodium	346	88
Lisinopril	Lisinopril	292	90
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	282	45
Losartan Potassium	Losartan Potassium	250	73
Amlodipine Besylate	Amlodipine Besylate	236	68
Gabapentin	Gabapentin	235	64
Metformin Hcl	Metformin Hcl	230	68
Trazodone Hcl	Trazodone Hcl	215	44
Hydrochlorothiazide	Hydrochlorothiazide	160	45
Omeprazole	Omeprazole	145	39
Furosemide	Furosemide	131	42
Potassium Chloride	Potassium Chloride	129	40
Metoprolol Tartrate	Metoprolol Tartrate	120	32
Pantoprazole Sodium	Pantoprazole Sodium	119	35
Baclofen	Baclofen	109	36
Duloxetine Hcl	Duloxetine Hcl	104	25
Famotidine	Famotidine	103	31
Glimepiride	Glimepiride	102	28
Jardiance	Empagliflozin	98	22
Metoprolol Succinate	Metoprolol Succinate	94	26
Buspirone Hcl	Buspirone Hcl	93	21
Glipizide	Glipizide	84	26
Rosuvastatin Calcium	Rosuvastatin Calcium	83	25
Simvastatin	Simvastatin	83	23
Tamsulosin Hcl	Tamsulosin Hcl	83	22
Sertraline Hcl	Sertraline Hcl	79	16
Carvedilol	Carvedilol	78	24
Fluticasone Propionate	Fluticasone Propionate	76	37
Tizanidine Hcl	Tizanidine Hcl	71	12
Clopidogrel	Clopidogrel Bisulfate	70	18
Ibuprofen	Ibuprofen	68	16
Alprazolam	Alprazolam	67	15
Ozempic	Semaglutide	65	13
Alendronate Sodium	Alendronate Sodium	64	19
Montelukast Sodium	Montelukast Sodium	61	18
Citalopram Hbr	Citalopram Hydrobromide	60	14
Tramadol Hcl	Tramadol Hcl	60	19
Albuterol Sulfate Hfa	Albuterol Sulfate	59	24
Januvia	Sitagliptin Phosphate	59	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	56	18
Hydralazine Hcl	Hydralazine Hcl	56	19
Pravastatin Sodium	Pravastatin Sodium	52	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	49	17
Triamcinolone Acetonide	Triamcinolone Acetonide	45	25
Ropinirole Hcl	Ropinirole Hcl	44	suppressed
Celecoxib	Celecoxib	42	suppressed
Bupropion Xl	Bupropion Hcl	40	15
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Atenolol	Atenolol	39	11
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Diclofenac Sodium	Diclofenac Sodium	38	15
Naproxen	Naproxen	38	14
Mounjaro	Tirzepatide	36	suppressed
Breyna	Budesonide/Formoterol Fumarate	35	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Metformin Hcl Er	Metformin Hcl	35	suppressed
Allopurinol	Allopurinol	33	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	12
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	32	17
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	12
Eliquis	Apixaban	30	11
Oxybutynin Chloride	Oxybutynin Chloride	30	12
Topiramate	Topiramate	30	12
Benazepril Hcl	Benazepril Hcl	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Sucralfate	Sucralfate	27	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Methadone Hcl	Methadone Hcl	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	20
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Folic Acid	Folic Acid	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Lorazepam	Lorazepam	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	20	suppressed
Primidone	Primidone	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Azithromycin	Azithromycin	19	17
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Ketoconazole	Ketoconazole	19	11
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Mupirocin	Mupirocin	18	14
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Amoxicillin	Amoxicillin	17	14
Clonidine Hcl	Clonidine Hcl	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Linzess	Linaclotide	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Temazepam	Temazepam	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Diazepam	Diazepam	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Emgality Pen	Galcanezumab-Gnlm	12	suppressed
Estradiol	Estradiol	12	suppressed
Promethazine-Dm	Promethazine/Dextromethorphan	12	11
Risperidone	Risperidone	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error